Cargando…
A219 BIOLOGIC USE DURING PREGNANCY IN WOMEN WITH INFLAMMATORY BOWEL DISEASE AND ASSOCIATED NEONATAL OUTCOMES: A RETROSPECTIVE CHART REVIEW
BACKGROUND: Biologics are the mainstay of therapy for patients with advanced inflammatory bowel disease (IBD). Most biologics readily undergo placental transfer during the second trimester and remain detectable in infant serum for up to 12 months. Therefore, most clinical guidelines currently recomm...
Autores principales: | Jeyakumar, Y, O'Connor, K, Huang, V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991354/ http://dx.doi.org/10.1093/jcag/gwac036.219 |
Ejemplares similares
-
A91 INTERACTIONS BETWEEN PREGNANCY, DELIVERY, AND ILEAL POUCH-ANAL ANASTOMOSIS FOR INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE CHART REVIEW
por: House, S C, et al.
Publicado: (2023) -
Optimizing maternal and neonatal outcomes through tight control management of inflammatory bowel disease during pregnancy: a pilot feasibility study
por: Jogendran, Rohit, et al.
Publicado: (2023) -
A214 WOMEN WITH INFLAMMATORY BOWEL DISEASE HAVE INCREASED HEALTH-CARE UTILIZATION DURING PREGNANCY AND POSTPARTUM COMPARED TO THOSE WITHOUT INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED COHORT STUDY
por: Tandon, P, et al.
Publicado: (2023) -
P219: Central line associated bloodstream infection surveillance adult ICU Kamc Riyadh 2012
por: Tannous, J, et al.
Publicado: (2013) -
P02.15. Acupuncture improves in vitro fertilization live birth outcomes: a retrospective chart review
por: Rubin, L Hullender, et al.
Publicado: (2012)